LOGO
LOGO

Lisata's Initial Results From Phase 2b Trial In Pancreatic Ductal Adenocarcinoma Due This Quarter

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News
rttnewslogo20mar2024

Lisata Therapeutics (LSTA) has key developments to watch, all revolving around its investigational drug, Certepetide.

Certepetide works by targeting specific alpha-v integrins (receptors) that are primarily expressed and overexpressed on tumor endothelial cells and tumor cells while sparing healthy tissue.

Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe Now
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update - April 27 – May 01, 2026

May 01, 2026 15:54 ET
Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.

RELATED NEWS
Latest Updates on COVID-19